Don’t let the cost of your migraine-prevention medication put your treatment at risk. We help eligible patients access brand-name Qulipta for $69.95 per month through the manufacturer’s Patient Assistance Program.
The Qulipta Patient Assistance Program is a manufacturer-sponsored initiative run by AbbVie that provides brand-name Qulipta at no medication cost to qualifying patients who cannot afford it. It is available to uninsured and underinsured U.S. residents who meet income requirements, and in some cases to Medicare Part D patients, reviewed case-by-case. If approved, you receive your Qulipta at no medication cost and can reapply each year.
AffordMyPrescriptions ensures the migraine-prevention medication you depend on is never out of reach. For a flat $69.95 per month, our Patient Advocates manage your enrollment, determine the right savings program for your situation, and coordinate your refills.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,550 | Save substantially |
| CVS Pharmacy | ~$1,585 | Save substantially |
| Walmart | ~$1,400 | Save substantially |
| Specialty pharmacy | Varies | Save substantially |
*Retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug-manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Many people search for Qulipta cost without insurance, Qulipta coupon, or atogepant price. Without insurance, Qulipta runs about $1,000–$1,600 per month, and there’s no generic, so brand pricing applies. For those who qualify, AbbVie’s Patient Assistance Program can provide brand-name Qulipta at no medication cost — we manage the entire application for a flat $69.95/month service fee.
Government-plan patients (Medicare, Medicaid) can’t use the manufacturer savings card; they should use the Patient Assistance Program instead. If you’re uninsured or struggling with Qulipta’s cost, we can check your eligibility and handle the application.
Consistent access to your migraine-prevention medication matters. We remove the administrative burden so you can focus on your health.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
If you have commercial or private insurance that covers Qulipta, the AbbVie Qulipta Complete Savings Card lets eligible commercially insured patients pay as little as $0 per month, up to a $7,000 maximum annual benefit. This answers searches like “Qulipta with commercial insurance,” “Qulipta cost with insurance,” and “Qulipta copay card.” If your plan won’t cover Qulipta or you’re on a government plan, our advocates switch you to the Patient Assistance Program.
If you’re searching for a Qulipta manufacturer coupon, copay card, or savings card, here’s the honest breakdown. AbbVie offers the Qulipta Complete Savings Card, which can bring your cost down to as little as $0 per month — but only if you have commercial (private) insurance that covers Qulipta. It is not valid for anyone on Medicare, Medicaid, or the uninsured. If the copay card doesn’t apply to you, that’s exactly where our Patient Assistance Program helps.
Copay accumulators may prevent savings from counting toward your deductible
Subject to strict monthly or annual maximum savings caps
If you have commercial insurance, the Qulipta Complete Savings Card is your cheapest option. If you’re on Medicare, uninsured, or the copay card doesn’t cover your situation, our Patient Assistance Program gets you brand-name Qulipta for a flat $69.95/month.
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation.
Qulipta (atogepant) is an oral CGRP receptor antagonist (a ‘gepant’) taken once daily to prevent episodic and chronic migraine in adults. It blocks CGRP, a protein involved in triggering migraine attacks, reducing how often migraines occur. There is no generic.
Yes. AbbVie offers the Qulipta Complete Savings Card, which can lower your cost to as little as $0 per month if you have commercial insurance that covers Qulipta. It is not available to Medicare, Medicaid, or uninsured patients — for them, the Patient Assistance Program is the better route, and we can help you apply.
Without insurance, Kaletra costs several hundred dollars per month; a generic lopinavir/ritonavir is cheaper.
Eligible uninsured/underinsured patients may receive brand-name Qulipta at no medication cost through AbbVie patient assistance. We handle the application for a flat $69.95/month.
Government-plan patients (Medicare, Medicaid) can’t use the manufacturer savings card; they should use the Patient Assistance Program instead.
The copay card lowers your insurance copay but needs commercial insurance and has caps. Patient assistance provides the medication itself at no cost for qualifying uninsured/underinsured patients, with no retail-price cap and ongoing renewals.
If you have commercial or private insurance that covers Qulipta, the AbbVie Qulipta Complete Savings Card lets eligible commercially insured patients pay as little as $0 per month, up to a $7,000 maximum annual benefit. This answers searches like “Qulipta with commercial insuranc…
If you’re struggling with the cost of Qulipta, our team may be able to help you access assistance programs designed to make your medication more affordable. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.